Defined daily dose (DDD) is arbitrary chosen technical unit for measuring medicament usage and it is not a recommended therapeutic dose. It is in fact a statistical parameter for monitoring medicaments usage, and it is related to the dose which is usually prescribed for the indication that the medicament was registered for. The aim of this work is to perform a detailed analysis of the extent and structure of the region of South Backa. Antiinfective medicaments in systematic use, according to the obtained data, participate with only 7.96 DDD/1000 inhabitants. The most applied pharmacotherapeutic subgroup with 2.99 DDD/1000 inhabitants is comprised of cephalexine and cephachlor.
Tomić Z, Čanković S, Stanulović M. Farmakoepidemiologija: Proučavanje upotrebe lekova sa ATC klasifikacijom. Priština.
2.
Stanulović M. Metode analize upotrebe lekova.
3.
Mazzaglia G, Greco S, Lando C, Encinotta G. Adult acute upper respiratory tract infections in Sicily: Pattern of antibiotic prescription in primary care. J Antimicrob Chemother. 41:259–66.
4.
Kiivet RA, Bergman U, Rootslane L, Rgo L, Sjqvist F. Drug use in Estonia in 1994-1995: a follow-up from 1989 and comparison with two Nordic countries. Eur J Clin Pharmacol. 54:119–24.
5.
Jakovljević V, Stanulović M. Upotreba lekova u Novom Sadu 1984. Pharmaca. 24:9–19.
6.
Beograd E. More rational drug utilization in primary health care in FR Yugoslavia.
7.
P MM, ML H, SD W, JG P. Antibiotic use in the Australian community 1990-1995. Act Med J Aust. 167:124–7.
8.
Vaccheri A, Castelvetri C, Esaka E, Del Favero A, Montanaro N. Pattern of antibiotic use in primary health care in Italy. Eur J Clin Pharmacol. 56:417–25.
9.
Mazzaglia G, Arcoraci V, Cutroneo P, Inferrera S, Alecci U, Bonfiglio S, et al. Infectious diseases in general practice and antibiotic prescription. Observational study in Sicily Recenti Prog Med. 89(7–8):356–60.
10.
Mazzaglia G, Greco S, Lando C, Encinotta G. Adult acute upper respiratory tract infections in Sicily: Pattern of antibiotic prescription in primary care. J Antimicrob Chemother. 41:259–66.
11.
Laurence DR, Bennett PN, Brown MJ. :476.
12.
Physicians Desk Reference.
13.
Avers’s Drug Treatment.
14.
British National Formulary, British Medical Association.
15.
M GT, JL HD, C OA, J OM, M SG. The utilization of anti-infective agents in primary care in La Rioja. Aten-Primaria. 22(9):574–9.
16.
Stanulović M, Jakovljević V, Sabo A. Lekovi u prometu 1999.
17.
Natsch S, Hekster YA, Jong R, Heerdink ER, Herings RM, Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis. 17(1):20–4.
18.
Ternak G, Almasi I. Utilization of antibiotics according to most frequent indications at Hungarian hospitals and results of surveys. Orv Hetil. 138(21):1333–9.
19.
Pecić J, Kulauzov M, Jelinić Z. Epidemiološka karakteristika rezistencije na antimikrobne lekove u periodu 1989-1994. Novi Sad Med fakultet. 1995:51–103.
20.
Prostran M, Todorović Z, M KT, Urednici. Antibiotici-juče, danas, sutra i princip racionalne primene. In: Prostran. p. 1–43.
21.
WHO: The Use of Essential Drugs. WHO Techn Report. 882:9–14.
22.
Sternon J, Serruys E, Liesnard C. Pharyngo-tonsilitis: Current clinical, bacteriological, serological and therapeutic aspects. Rev Med Brux. 16(5):344–8.
23.
Radulović S, Milutinović O, Brailo I. Analiza potrošnje antimikrobnih lekova u Jugoslaviji u razdoblju 1984-1986. Pharmaca. 25:183–9.
24.
Esposito S, Ritis G, DErrico G, Noviello S, Ianniello F. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. 20(1):72–9.
25.
Couper MR. Strategies for the rational use of antimicrobials. Division of Drug Management and Policies, World Health Organization, Geneva, Switzerland. Clin Infect Dis. 24(1):154–6.
26.
Group SW. Antimicrobial Resistance. Bulletin of the World Health Organization. 61:383–94.
27.
Kažić T, M KT, urednici. Upotreba antibiotika u Jugoslaviji 1991-1994. In: Prostran. p. 43–54.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
